Parabilis Medicines Statistics
NASDAQ: PBLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
28.82-0.04 (-0.14%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 29.00 +0.62%
Parabilis Medicines by the numbers
Parabilis Medicines has a market capitalization of $3.56 billion based on 121.95M shares outstanding. With trailing EPS of $-9.51, Parabilis Medicines is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.4% below its 50-day average and 13.7% below its 200-day average.
Average daily trading volume is 670.37K shares, or about $19.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PBLS valuation vs. peer median
| Metric | PBLS | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.56B | $3.57B | -0% |
| Avg. volume | 670.37K | 2.35M | -71% |
Peer median across 8 companies: XENE, IDYA, AMLX, OGN, VKTX, ACAD, TNGX, LEGN.
Valuation
- Market cap
- $3.56B
- EPS (TTM)
- $-9.51
- Shares outstanding
- 121.95M
Price and trading
- Previous close
- 28.86
- Open
- 28.80
- Day range
- 27.56 – 30.36
- 52-week range
- 24.51 – 42.49
- Beta
- —
- Volume
- 994.00K
- Average volume
- 670.37K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 3.56B
- Forward Pe
- -13.18
- Eps
- -9.51
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 42.49
- Week52 Low
- 24.51
- Avg Volume
- 670.37K
- Shares Outstanding
- 121.95M
- Ma50
- 36.21
- Ma200
- 33.41
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -32.17%
- Pct From52w Low
- 17.58%